Zobrazeno 1 - 10
of 2 661
pro vyhledávání: '"A, Frega"'
Autor:
Proença, Marina, Costa, Bruna Cescatto, Didonet, Simone Regina, Machado Toaldo, Ana Maria, Martins, Tomas Sparano, Frega, José Roberto
Publikováno v:
Management Research Review, 2023, Vol. 47, Issue 5, pp. 744-766.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/MRR-05-2023-0350
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract In patients suffering from cerebral ischemic stroke, there is an urgent need for treatments to protect stressed yet viable brain cells. Recently, treatment strategies that induce neuronal activity have been shown to be neuroprotective. Here,
Externí odkaz:
https://doaj.org/article/b826547b64ba40aca80a650968cee938
Autor:
Daniela Polese, Flavia Costanzi, Paola Bianchi, Antonio Frega, Filippo Bellati, Maria Paola De Marco, Pasquale Parisi, Oliviero Bruni, Donatella Caserta, Giuliana Cozza
Publikováno v:
BMC Women's Health, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background The sars-Cov-2 pandemic has determined psychological stress, particularly in the young population of medical students. We studied the impact of the pandemic on menstrual cycle alteration in relation to psychological stress, presen
Externí odkaz:
https://doaj.org/article/6371892c8da2499a9a4c9bfcaf28db96
Autor:
Giulia Pasello, Alberto Pavan, Mattia De Nuzzo, Stefano Frega, Alessandra Ferro, Alessandro Dal Maso, Laura Bonanno, Valentina Guarneri, Fabio Girardi
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionRandomized clinical trials (RCTs) represent the mainstay for the approval of new treatments. However, stringent inclusion criteria often cause them to depart from the daily clinical practice. Real-world (RW) evidence have a complementing
Externí odkaz:
https://doaj.org/article/c1ca128ba78b4aa2be51fa68df6d3251
Autor:
Laura Bonanno, Paola Del Bianco, Valentina Guarneri, Fiorella Calabrese, Antonio Rosato, Anna Tosi, Martina Lorenzi, Anna Roma, Alberto Pavan, Antonio Scapinello, Maria Vittoria Resi, Stefano Frega, Giulia Pasello
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Purpose Small-cell lung cancer (SCLC) is an aggressive disease with a dismal prognosis. The addition of immune checkpoints inhibitors to standard platinum-based chemotherapy in first-line setting achieves a durable benefit only in a patient subgroup.
Externí odkaz:
https://doaj.org/article/905ba62164a94761bf5829ce84a3adb3
Autor:
Heuvelmans, Anouk M., Proietti Onori, Martina, Frega, Monica, de Hoogen, Jeffrey D., Nel, Eveline, Elgersma, Ype, van Woerden, Geeske M.
Publikováno v:
In Experimental Neurology September 2024 379
Autor:
Scattolin, Daniela, Maso, Alessandro Dal, Ferro, Alessandra, Frega, Stefano, Bonanno, Laura, Guarneri, Valentina, Pasello, Giulia
Publikováno v:
In Cancer Treatment Reviews July 2024 128
Autor:
Andrea Palloni, Silvia Bisello, Ilaria Maggio, Maria Massucci, Andrea Galuppi, Alessandro Di Federico, Alessandro Rizzo, Angela Dalia Ricci, Giambattista Siepe, Alessio Giuseppe Morganti, Giovanni Brandi, Giorgio Frega
Publikováno v:
Current Oncology, Vol 30, Iss 5, Pp 4754-4766 (2023)
(1) Background: Biliary tract cancers (BTCs) are a heterogeneous group of neoplasms with dismal prognosis and the role of adjuvant chemoradiotherapy in high-risk resected patients is unclear. (2) Methods: We retrospectively analyzed the outcomes of B
Externí odkaz:
https://doaj.org/article/a721ba363748424bb0565315716bb2c5
Autor:
Martina Lorenzi, Maria Vittoria Resi, Laura Bonanno, Stefano Frega, Alessandro Dal Maso, Alessandra Ferro, Valentina Guarneri, Giulia Pasello
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Extensive stage-Small-Cell Lung Cancer (ES-SCLC) is an aggressive cancer with dismal prognosis. The addition of immune-checkpoint inhibitors (ICIs) to platinum-based chemotherapy have been consistently demonstrated to improve outcomes and survival, b
Externí odkaz:
https://doaj.org/article/a6003ae210014e61ae04728c008d1f67
Autor:
Laura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, Alberto Pavan, Loc Carlo Bao, Mattia De Nuzzo, Stefano Frega, Giulia Sartori, Alessandra Ferro, Giulia Pasello, Paolo Morandi, Giuseppe Aprile, Valentina Guarneri
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundRecent clinical trials demonstrated longer survival in extended small cell lung cancer (SCLC) patients treated with immunotherapy in addition to chemotherapy. However, the magnitude of benefit is modest and the impact in real-world setting
Externí odkaz:
https://doaj.org/article/ebb6c0a9fefe486f86d7906a97795967